BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1258 related articles for article (PubMed ID: 17604583)

  • 21. Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
    Rodriguez CP; Adelstein DJ; Rybicki LA; Saxton JP; Lorenz RR; Wood BG; Strome M; Esclamado RM; Lavertu P; Carroll MA
    Head Neck; 2008 Dec; 30(12):1535-42. PubMed ID: 18704968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy.
    Lecanu JB; Monceaux G; Périé S; Angelard B; St Guily JL
    Laryngoscope; 2000 Mar; 110(3 Pt 1):412-6. PubMed ID: 10718429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current role for induction chemotherapy in head and neck tumors].
    Dietz A; Keilholz U; Werner J; Hagen R; Flentje M; Iro H
    Laryngorhinootologie; 2008 Apr; 87(4):237-43; discussion 244. PubMed ID: 18365986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of treatment of inoperable recurrences of laryngeal cancer after total laryngectomy.
    Sas-Korczyńska B; Korzeniowski S; Skolyszewski J
    Strahlenther Onkol; 1996 Feb; 172(2):99-102. PubMed ID: 8669051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Collision tumor of a hypopharyngeal adenoidcystic carcinoma and a laryngeal squamous cell carcinoma].
    Kufeld M; Junker K; Sudhoff H; Dazert S
    Laryngorhinootologie; 2004 Jan; 83(1):51-4. PubMed ID: 14740306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
    Lefebvre JL; Pointreau Y; Rolland F; Alfonsi M; Baudoux A; Sire C; de Raucourt D; Malard O; Degardin M; Tuchais C; Blot E; Rives M; Reyt E; Tourani JM; Geoffrois L; Peyrade F; Guichard F; Chevalier D; Babin E; Lang P; Janot F; Calais G; Garaud P; Bardet E
    J Clin Oncol; 2013 Mar; 31(7):853-9. PubMed ID: 23341517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The assessment of pharyngocutaneous fistula rate in patients treated primarily with definitive radiotherapy followed by salvage surgery of the larynx and hypopharynx.
    Dirven R; Swinson BD; Gao K; Clark JR
    Laryngoscope; 2009 Sep; 119(9):1691-5. PubMed ID: 19544379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The results and toxicity of organ preservation treatment for locoregionally advanced laryngeal and hypopharyngeal cancer].
    Kiprian D; Kawecki A; Jarząbski A; Michalski W; Pawłowska-Sendułka B
    Otolaryngol Pol; 2011; 65(5):363-8. PubMed ID: 22078287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches.
    Gupta T; Chopra S; Agarwal JP; Laskar SG; D'cruz AK; Shrivastava SK; Dinshaw KA
    Acta Oncol; 2009; 48(4):541-48. PubMed ID: 18979267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of concurrent chemoradiation in laryngeal preservation for supraglottic cancer.
    Yoon TM; Lee JK; Cho JS; Lim SC; Chung WK
    J Otolaryngol Head Neck Surg; 2010 Apr; 39(2):142-9. PubMed ID: 20211100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation.
    Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Kawakami M; Watanabe M; Niho T; Abo H; Yamomoto S
    Anticancer Res; 2009 Feb; 29(2):661-6. PubMed ID: 19331217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Salvage surgery in laryngeal and hypopharyngeal carcinoma].
    Pawlik AB; Stöckli SJ; Schmid S
    Schweiz Med Wochenschr Suppl; 2000; 116():27S-30S. PubMed ID: 10780066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early outcomes after transoral CO2 laser resection of laryngeal and hypopharyngeal squamous cell carcinoma: one centre's experience.
    Leong SC; Kathan C; Mortimore S
    J Laryngol Otol; 2010 Feb; 124(2):185-93. PubMed ID: 19954558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
    Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
    Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Apropos of two recently published randomized trials of induction chemotherapy in nasopharyngeal and piriform sinus carcinoma].
    de Crevoisier R; Mazeron JJ
    Bull Cancer Radiother; 1996; 83(3):174-6. PubMed ID: 8977570
    [No Abstract]   [Full Text] [Related]  

  • 38. Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results.
    Semrau S; Waldfahrer F; Lell M; Linke R; Klautke G; Kuwert T; Uder M; Iro H; Fietkau R
    Strahlenther Onkol; 2011 Jan; 187(1):15-22. PubMed ID: 21234526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperfractionated radiotherapy and concomitant cisplatin for locally advanced laryngeal and hypopharyngeal carcinomas: final results of a single institutional program.
    de la Vega FA; García RV; Domínguez D; Iturre EV; López EM; Alonso SM; Romero P; Sola JM
    Am J Clin Oncol; 2003 Dec; 26(6):550-7. PubMed ID: 14663370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol.
    de Andrés L; Brunet J; López-Pousa A; Burgués J; Quer M; León X; Guedea F; Vega M; Mesía R; López JJ
    Laryngoscope; 1995 Aug; 105(8 Pt 1):822-6. PubMed ID: 7630294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.